Kayla Kawamura, - Medicare Speech-Language Pathologist in Wahiawa, HI

Kayla Kawamura, is a medicare enrolled "Speech-language Pathologist" provider in Wahiawa, Hawaii. Her current practice location is Wai'anae &, Ayres Ave, Wahiawa, Hawaii. You can reach out to her office (for appointments etc.) via phone at (808) 358-0041.

Kayla Kawamura is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1922692334.

Contact Information

Kayla Kawamura,
Wai'anae &, Ayres Ave,
Wahiawa, HI 96786-9678
(808) 358-0041
Not Available



Healthcare Provider's Profile

Full NameKayla Kawamura
GenderFemale
SpecialitySpeech-language Pathologist
LocationWai'anae &, Ayres Ave, Wahiawa, Hawaii
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1922692334
  • Provider Enumeration Date: 02/25/2021
  • Last Update Date: 02/25/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 6103217294
  • Enrollment ID: I20211228001278

Medical Identifiers

Medical identifiers for Kayla Kawamura such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1922692334NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Kayla Kawamura allows following entities to bill medicare on her behalf.
Provider NameUniversity Clinical Education & Research Associates
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1013966845
PECOS PAC ID: 1658275847
Enrollment ID: O20031120000276

News Archive

Ultrafine particle exposure may affect cardiac function

The adverse health effects caused by fine particles have been known for some time. In addition, ultrafine particles appear to play a significant role in cardiac function - even if an individual is exposed to these for only a few minutes, as scientists of Helmholtz Zentrum München have now been able to show.

Natural compound in snake venom for treatment of malignant tumours

Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.

New autism early intervention centers promised for Mackay and Bundaberg

The Queensland Government has announced $1 million a year over three years for new autism centers in Bundaberg and Mackay. These will provide care and also early intervention services to the substantial number of autistic children in the region.

Eliminating the Cold Chain with COVID-19 Molecular Transport Media

In this interview, Rebekah Stibbs from EKF Diagnostics talks to News-Medical about eliminating the cold chain with COVID-19 molecular transport media.

Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kayla Kawamura is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kayla Kawamura,
95-1116 Kualapa St,
Mililani, HI 96789-4280

Ph: () -
Kayla Kawamura,
Wai'anae &, Ayres Ave,
Wahiawa, HI 96786-9678

Ph: (808) 358-0041

News Archive

Ultrafine particle exposure may affect cardiac function

The adverse health effects caused by fine particles have been known for some time. In addition, ultrafine particles appear to play a significant role in cardiac function - even if an individual is exposed to these for only a few minutes, as scientists of Helmholtz Zentrum München have now been able to show.

Natural compound in snake venom for treatment of malignant tumours

Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.

New autism early intervention centers promised for Mackay and Bundaberg

The Queensland Government has announced $1 million a year over three years for new autism centers in Bundaberg and Mackay. These will provide care and also early intervention services to the substantial number of autistic children in the region.

Eliminating the Cold Chain with COVID-19 Molecular Transport Media

In this interview, Rebekah Stibbs from EKF Diagnostics talks to News-Medical about eliminating the cold chain with COVID-19 molecular transport media.

Protalix receives FDA CRL for taliglucerase alfa NDA for Gaucher disease

Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).

Read more News

› Verified 8 days ago


Speech-Language Pathologist in Wahiawa, HI

Justin Guerrero Tano,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1684 Nakula St, Wahiawa, HI 96786
Phone: 808-220-2909    
Winona Lam,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1136 California Ave, Wahiawa, HI 96786
Phone: 808-485-5136    
Mrs. Janice Kuioka Cole, M.A.
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 128 Lehua St, Wahiawa, HI 96786
Phone: 808-621-8411    
Mrs. Sandra Elizabeth Carlson, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 330 Walker Ave, Wahiawa, HI 96786
Phone: 808-622-6329    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.